{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:35:04Z","timestamp":1793043304863,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.vaccine.2006.08.011","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T22:00:01Z","timestamp":1156543201000},"page":"729-740","source":"Crossref","is-referenced-by-count":200,"title":["Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate Fc\u03b3RII-dependent entry into B cells in vitro"],"prefix":"10.1016","volume":"25","author":[{"given":"Yiu Wing","family":"Kam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Kien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjeanette","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Chung","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine W.","family":"Lamirande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leatrice","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui Ling","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Guarner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif R.","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanta","family":"Subbarao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Nal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Altmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2006.08.011_bib1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm1024","article-title":"Identification of a new human coronavirus","volume":"10","author":"van der Hoek","year":"2004","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2006.08.011_bib2","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/JVI.79.2.884-895.2005","article-title":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia","volume":"79","author":"Woo","year":"2005","journal-title":"J Virol"},{"issue":"12 Suppl","key":"10.1016\/j.vaccine.2006.08.011_bib3","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/nm1143","article-title":"Severe acute respiratory syndrome","volume":"10","author":"Peiris","year":"2004","journal-title":"Nat Med"},{"issue":"16","key":"10.1016\/j.vaccine.2006.08.011_bib4","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J Virol"},{"issue":"19","key":"10.1016\/j.vaccine.2006.08.011_bib5","doi-asserted-by":"crossref","first-page":"10328","DOI":"10.1128\/JVI.78.19.10328-10335.2004","article-title":"Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein","volume":"78","author":"Song","year":"2004","journal-title":"J Virol"},{"issue":"6965","key":"10.1016\/j.vaccine.2006.08.011_bib6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2006.08.011_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbrc.2004.01.076","article-title":"Expression cloning of functional receptor used by SARS coronavirus","volume":"315","author":"Wang","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"44","key":"10.1016\/j.vaccine.2006.08.011_bib8","doi-asserted-by":"crossref","first-page":"15748","DOI":"10.1073\/pnas.0403812101","article-title":"CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus","volume":"101","author":"Jeffers","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.vaccine.2006.08.011_bib9","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1128\/JVI.78.11.5642-5650.2004","article-title":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN","volume":"78","author":"Yang","year":"2004","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.08.011_bib10","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.0306446101","article-title":"Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry","volume":"101","author":"Simmons","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.vaccine.2006.08.011_bib11","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1128\/JVI.78.12.6134-6142.2004","article-title":"S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients","volume":"78","author":"Hofmann","year":"2004","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.08.011_bib12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/423286","article-title":"Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection","volume":"190","author":"Nie","year":"2004","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2006.08.011_bib13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/427242","article-title":"Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice","volume":"191","author":"Greenough","year":"2005","journal-title":"J Infect Dis"},{"issue":"9427","key":"10.1016\/j.vaccine.2006.08.011_bib14","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(04)16506-9","article-title":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets","volume":"363","author":"ter Meulen","year":"2004","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2006.08.011_bib15","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/JVI.78.7.3572-3577.2004","article-title":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice","volume":"78","author":"Subbarao","year":"2004","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2006.08.011_bib16","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1073\/pnas.0401939101","article-title":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice","volume":"101","author":"Bisht","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.vaccine.2006.08.011_bib17","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm1080","article-title":"An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus","volume":"10","author":"Traggiai","year":"2004","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.vaccine.2006.08.011_bib18","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1128\/JVI.79.10.5900-5906.2005","article-title":"Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants","volume":"79","author":"Sui","year":"2005","journal-title":"J Virol"},{"issue":"6982","key":"10.1016\/j.vaccine.2006.08.011_bib19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice","volume":"428","author":"Yang","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2006.08.011_bib20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.virol.2005.01.042","article-title":"Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein","volume":"334","author":"Bisht","year":"2005","journal-title":"Virology"},{"issue":"17","key":"10.1016\/j.vaccine.2006.08.011_bib21","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1016\/j.vaccine.2006.01.059","article-title":"A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice","volume":"24","author":"Zhou","year":"2006","journal-title":"Vaccine"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2006.08.011_bib22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1099\/vir.0.81579-0","article-title":"Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus","volume":"87","author":"See","year":"2006","journal-title":"J Gen Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2006.08.011_bib23","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.vaccine.2005.06.038","article-title":"Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine","volume":"24","author":"Qin","year":"2006","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2006.08.011_bib24","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1128\/JVI.78.22.12672-12676.2004","article-title":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets","volume":"78","author":"Weingartl","year":"2004","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.08.011_bib25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1073\/pnas.0409065102","article-title":"Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses","volume":"102","author":"Yang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.vaccine.2006.08.011_bib26","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/JVI.64.3.1407-1409.1990","article-title":"Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization","volume":"64","author":"Vennema","year":"1990","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.08.011_bib27","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1128\/JVI.66.2.956-965.1992","article-title":"Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages","volume":"66","author":"Olsen","year":"1992","journal-title":"J Virol"},{"issue":"6961","key":"10.1016\/j.vaccine.2006.08.011_bib28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/425915a","article-title":"Virology: SARS virus infection of cats and ferrets","volume":"425","author":"Martina","year":"2003","journal-title":"Nature"},{"issue":"6937","key":"10.1016\/j.vaccine.2006.08.011_bib29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/423240a","article-title":"Aetiology: Koch's postulates fulfilled for SARS virus","volume":"423","author":"Fouchier","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2006.08.011_bib30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/JVI.79.1.503-511.2005","article-title":"Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters","volume":"79","author":"Roberts","year":"2005","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2006.08.011_bib31","doi-asserted-by":"crossref","first-page":"20358","DOI":"10.1074\/jbc.M301284200","article-title":"DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2","volume":"278","author":"Lozach","year":"2003","journal-title":"J Biol Chem"},{"issue":"45","key":"10.1016\/j.vaccine.2006.08.011_bib32","doi-asserted-by":"crossref","first-page":"35137","DOI":"10.1074\/jbc.M003868200","article-title":"Processing, stability, and receptor binding properties of oligomeric envelope glycoprotein from a primary HIV-1 isolate","volume":"275","author":"Staropoli","year":"2000","journal-title":"J Biol Chem"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2006.08.011_bib33","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1099\/vir.0.80671-0","article-title":"Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E.","volume":"86","author":"Nal","year":"2005","journal-title":"J Gen Virol"},{"issue":"37","key":"10.1016\/j.vaccine.2006.08.011_bib34","doi-asserted-by":"crossref","first-page":"13584","DOI":"10.1073\/pnas.0405297101","article-title":"A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs","volume":"101","author":"Matoba","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2006.08.011_bib35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0264-410X(97)00168-0","article-title":"Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant","volume":"16","author":"Wu","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.08.011_bib36","first-page":"493","article-title":"A simple method for estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"issue":"31","key":"10.1016\/j.vaccine.2006.08.011_bib37","doi-asserted-by":"crossref","first-page":"32035","DOI":"10.1074\/jbc.M402296200","article-title":"C-type Lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles","volume":"279","author":"Lozach","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2006.08.011_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1572-0241.2005.40377.x","article-title":"Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases","volume":"100","author":"Shi","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.vaccine.2006.08.011_bib39","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0264-410X(97)00305-8","article-title":"Comparison of the immunological and protective responses elicited by microencapsulated formulations of the F1 antigen from Yersinia pestis","volume":"16","author":"Reddin","year":"1998","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2006.08.011_bib40","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1006\/viro.1998.9315","article-title":"Expression of immunogenic glycoprotein S polypeptides from transmissible gastroenteritis coronavirus in transgenic plants","volume":"249","author":"Gomez","year":"1998","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2006.08.011_bib41","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbrc.2004.09.106","article-title":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine","volume":"324","author":"He","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.08.011_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0168-1702(96)01390-1","article-title":"Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies","volume":"46","author":"Anton","year":"1996","journal-title":"Virus Res"},{"issue":"11","key":"10.1016\/j.vaccine.2006.08.011_bib43","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1128\/JVI.64.11.5367-5375.1990","article-title":"Assembly of coronavirus spike protein into trimers and its role in epitope expression","volume":"64","author":"Delmas","year":"1990","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.vaccine.2006.08.011_bib44","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0264-410X(95)00011-O","article-title":"Adjuvants for human vaccines-current status, problems and future prospects","volume":"13","author":"Gupta","year":"1995","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2006.08.011_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3201\/eid0602.000204","article-title":"Vaccines for mucosal immunity to combat emerging infectious diseases","volume":"6","author":"van Ginkel","year":"2000","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2006.08.011_bib46","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1128\/JVI.80.8.4079-4087.2006","article-title":"Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice","volume":"80","author":"Lee","year":"2006","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.08.011_bib47","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","article-title":"Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract","volume":"173","author":"Renegar","year":"2004","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2006.08.011_bib48","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.4049\/jimmunol.174.8.4908","article-title":"Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies","volume":"174","author":"He","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.08.011_bib49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.virol.2005.01.034","article-title":"Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines","volume":"334","author":"He","year":"2005","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.vaccine.2006.08.011_bib50","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1073\/pnas.0307140101","article-title":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association","volume":"101","author":"Sui","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"10.1016\/j.vaccine.2006.08.011_bib51","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1128\/JVI.78.13.6938-6945.2004","article-title":"Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies","volume":"78","author":"Zhang","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2006.08.011_bib52","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv Virus Res"},{"issue":"1","key":"10.1016\/j.vaccine.2006.08.011_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/infdis\/128.1.15","article-title":"Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection","volume":"128","author":"Halstead","year":"1973","journal-title":"J Infect Dis"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2006.08.011_bib54","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1017\/S0031182097001819","article-title":"Enhancing antibodies in HIV infection","volume":"115","author":"Fust","year":"1997","journal-title":"Parasitology"},{"issue":"5","key":"10.1016\/j.vaccine.2006.08.011_bib55","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1128\/JVI.75.5.2324-2330.2001","article-title":"Infectivity-enhancing antibodies to Ebola virus glycoprotein","volume":"75","author":"Takada","year":"2001","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.08.011_bib56","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/rmv.405","article-title":"Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications","volume":"13","author":"Takada","year":"2003","journal-title":"Rev Med Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.08.011_bib57","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1399-0039.2005.00476.x","article-title":"Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome","volume":"66","author":"Yuan","year":"2005","journal-title":"Tissue Antigens"},{"issue":"33","key":"10.1016\/j.vaccine.2006.08.011_bib58","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1073\/pnas.0505577102","article-title":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry","volume":"102","author":"Simmons","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"35","key":"10.1016\/j.vaccine.2006.08.011_bib59","doi-asserted-by":"crossref","first-page":"12543","DOI":"10.1073\/pnas.0503203102","article-title":"Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection","volume":"102","author":"Matsuyama","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"10.1016\/j.vaccine.2006.08.011_bib60","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.0400576101","article-title":"Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides","volume":"101","author":"Bosch","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 4","key":"10.1016\/j.vaccine.2006.08.011_bib61","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1099\/0022-1317-74-4-745","article-title":"Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious peritonitis virus infectivity","volume":"74","author":"Olsen","year":"1993","journal-title":"J Gen Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.08.011_bib62","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1128\/JVI.69.5.2858-2862.1995","article-title":"Localization of antigenic sites of the S glycoprotein of feline infectious peritonitis virus involved in neutralization and antibody-dependent enhancement","volume":"69","author":"Corapi","year":"1995","journal-title":"J Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2006.08.011_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08830189709045701","article-title":"Structural bases of Fc gamma R functions","volume":"16","author":"Daeron","year":"1997","journal-title":"Int Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.08.011_bib64","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20050828","article-title":"Multiple organ infection and the pathogenesis of SARS","volume":"202","author":"Gu","year":"2005","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.vaccine.2006.08.011_bib65","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3201\/eid1108.041003","article-title":"SARS vaccine protective in mice","volume":"11","author":"Stadler","year":"2005","journal-title":"Emerg Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06009534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06009534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T00:44:53Z","timestamp":1587170693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06009534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0264410X06009534"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.08.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}